VACCINATION SITE MASS

This adverse event was reported 41 times

VACCINATION SITE MASS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DILUENT 2 0.0019
1 GONADOTROPHIN, CHORIONIC 1 0.0016
2 CETRORELIX ACETATE 1 0.0016
3 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 1 0.0002
4 HUMAN IMMUNOGLOBULIN G 3 0.0001
5 TIMOLOL MALEATE OPHTHALMIC 1 0.0001
6 TIMOLOL MALEATE 1 0.0001
7 PRIMIDONE 1 0.0001
8 INSULIN ASPART 6 0.0001
9 INSULIN GLARGINE-YFGN 2 0.0001
See all drugs enriched for association with VACCINATION SITE MASS

VACCINATION SITE MASS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 3 0.0001
1 Complement Inhibitor [EPC] 6 0.0001
2 Leukotriene Receptor Antagonist [EPC] 3 0.0001
3 Progesterone [EPC] 1 0.0000
4 Macrolide Antimicrobial [EPC] 2 0.0000
5 Insulin Analog [EPC] 10 0.0000
6 Fluoroquinolone Antibacterial [EPC] 2 0.0000
7 Tetracycline-class Drug [EPC] 1 0.0000
8 Cardiac Glycoside [EPC] 1 0.0000
9 GLP-1 Receptor Agonist [EPC] 6 0.0000
See all drug classes enriched for association with VACCINATION SITE MASS